Chemotherapy and amenorrhea: Risks and treatment options

Current Opinion in Obstetrics and Gynecology

Volumn 20, Issue 4, 2008, Pages 408-415

  Oktay, Kutluk ^a,b,d   Sönmezer, Murat ^c  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b CENTER FOR HUMAN REPRODUCTION   (United States)

^c ANKARA UNIVERSITY   (Turkey)

^d Institute for Fertility Preservation   (United States)

Author keywords

Chemotherapy; Fertility preservation; Ovarian reserve

Indexed keywords

ALKYLATING AGENT; ANASTROZOLE; ANTHRACYCLINE; AROMATASE INHIBITOR; BLEOMYCIN; BUSULFAN; CHLORAMBUCIL; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; FOLLITROPIN; GONADORELIN; GONADOTROPIN; INHIBIN B; LETROZOLE; MELPHALAN; METHOTREXATE; MUELLERIAN INHIBITING FACTOR; PACLITAXEL; PROCARBAZINE; TAMOXIFEN; TAXANE DERIVATIVE; VINCRISTINE; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE;

ADJUVANT THERAPY; AMENORRHEA; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RISK; CELL DEATH; CELL LOSS; CHILD; CRYOPRESERVATION; DNA STRAND BREAKAGE; DONOR; DRUG EFFICACY; DRUG SAFETY; ENDOMETRIUM CANCER; EXPERIMENTAL STUDY; FEMALE FERTILITY; FERTILIZATION IN VITRO; FREEZE THAWING; GERMINAL VESICLE; GONAD FUNCTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; IN VITRO STUDY; INFERTILITY; INFERTILITY THERAPY; LOW DRUG DOSE; MENSTRUAL CYCLE; OOCYTE; OOCYTE MATURATION; OVARIAN PRESERVATION; OVARIAN RESERVE; OVARY FOLLICLE; OVARY FOLLICLE CELL; OVARY FUNCTION; OVARY INSUFFICIENCY; PATIENT COUNSELING; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; REVIEW; SICKLE CELL ANEMIA; SIDE EFFECT; TISSUE PRESERVATION; XENOGRAFT; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FEMALE; IMMUNOSUPPRESSIVE TREATMENT;

AMENORRHEA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CRYOPRESERVATION; FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HUMANS; OOCYTES; OVARIAN FAILURE, PREMATURE; TRANSPLANTATION CONDITIONING;

EID: 56749087906     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/GCO.0b013e328307ebad     Document Type: Review

References (44)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics. CA Cancer J Clin 2007; 57:43-66.
2. Sonmezer M, Oktay K. Fertility preservation in female patients. Hum Reprod Update 2004; 10:251-266.
3. Oktem O, Oktay K. Quantitative assessment of the impact of chemotherapy on ovarian follicle reserve and stromal function. Cancer 2007; 110:2222-2229.
4. Oktem O, Oktay K. A novel ovarian xenografting model to characterize the impact of chemotherapy agents on human primordial follicle reserve. Cancer Res 2007; 67:10159-10162.
5. Sonmezer M, Oktay K. Fertility preservation in young women undergoing breast cancer therapy. Oncologist 2006; 11:422-434.
6. Stone ER, Slack RS, Vovielli A, et al. Rate of chemotherapy related amenorrhea associated with adjuvant Adriamycin and Cytoxan and Adriamycin and Cytoxan followed by Taxol in early stage breast cancer. Breast Cancer Res Treat 2000; 64:61a.
7. Nabholtz J, Pienkowski T, Mackey J, et al. Phase III trial comparing TAC (docetaxel, doxorubicin, cyclophosphamide) with FAC (5-fluorouracil, doxorubicin, cyclophosphamide) in the adjuvant treatment of node positive breast cancer (BC) patients: interim analysis of the BCIRG 001 study. Proc Am Soc Clin Oncol 2002; 21:36a.
8. Martin M, Pienkowski T, Mackey J, et al. Adjuvant docetaxel for nodepositive breast cancer. N Engl J Med 2005; 352:2302-2313.
9. Fornier MN, Modi S, Panageas KS, et al. Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane. Cancer 2005; 104:1575-1579.
10. Reh A, Oktem O, Oktay K. Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers. Fertil Steril 2007 [Epub ahead of print].
11. Tham YL, Sexton K, Weiss H, et al. The rates of chemotherapy-induced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxane. Am J Clin Oncol 2007; 30:126-132.
12. Mintzer DM, Davis AL, Klitus M. Chemotherapy-induced amenorrhea from adjuvant breast cancer treatment: the effect of taxanes. J Clin Oncol 2004; 22 (Suppl):687.
13. Bernhard J, Zahrieh D, Castiglione-Gertsch M, et al. Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients - the International Breast Cancer Study Group Trial VIII. J Clin Oncol 2007; 25:263-270.
14. Chemaitilly W, MertensAC, Mitby P, et al. Acute ovarian failure in the childhood cancer survivor study. J Clin Endocrinol Metab 2006; 91: 1723-1728.
15. BrachetC, Heinrichs C, Tenoutasse S, et al. Children with sickle cell disease: growth and gonadal function after hematopoietic stem cell transplantation. J Pediatr Hematol Oncol 2007; 29:445-450.
16. Sklar CA, Mertens AC, Mitby P, et al. Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study. J Natl Cancer Inst 2006; 98:890-896.
17. Rahhal SN, Eugster EA. Unexpected recovery of ovarian function many years after bone marrow transplantation. J Pediatr 2008; 152:289-290.
18. Kwee J, Schats R, McDonnell J, et al. Evaluation of anti-Mullerian hormone as a test for the prediction of ovarian reserve. Fertil Steril 2007 [Epub ahead of print].
19. Anderson RA, Themmen AP, Al-Qahtani A, et al. The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer. Hum Reprod 2006; 21:2583-2592.
20. Schmidt KLT, Andersen CY, Loft A, et al. Follow-up of ovarian function postchemotherapy following ovarian cryopreservation and transplantation. Hum Reprod 2005; 20:3539-3546.
21. van Beek RD, van den Heuvel-Eibrink MM, Laven JS. Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood. J Clin Endocrinol Metab 2007; 92:3869-3874.
22. Oktay K, Oktem O, Reh A, Vahdat L. Measuring the impact of chemotherapy on fertility in women with breast cancer. J Clin Oncol 2006; 24:4044-4046.
23. Giuseppe L, Attilio G, Edoardo DN, et al. Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD). Hematology 2007; 12:141 -147.
24. Lie Fong S, Lugtenburg PJ, Schipper I, et al. Antimullerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematological malignancies. Hum Reprod 2008; 23:674-678.
25. Veeck LL, Bodine R, Clarke RN, et al. High pregnancy rates can be achieved after freezing and thawing human blastocysts. Fertil Steril 2004; 82:1418-1427.
26. Oktay K, Buyuk E, Libertella N, et al. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol 2005; 23:4347-4353.
27. Azim A, Costantini-Ferrando M, Oktay K. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in breast cancer patients: a prospective controlled study. J Clin Oncol 2008; 26:2630-2635.
28. Oktay K, Hourvitz A, Sahin G, et al. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab 2006; 91:3885- 3890.
29. Azim AA, Costantini-Ferrando M, Lostritto K, Oktay K. Relative potencies of anastrozole and letrozole to suppress estradiol in breast cancer patients undergoing ovarian stimulation before in vitro fertilization. J Clin Endocrinol Metab 2007; 92:2197-2200.
30. Azim A, Oktay K. Letrozole for ovulation induction and fertility preservation by embryo cryopreservation in young women with endometrial carcinoma. Fertil Steril 2007; 88:657-664.
31. Oktay K, Cil AP, Bang H. Efficiency of oocyte cryopreservation: a meta-analysis. Fertil Steril 2006; 86:70-80.
32. Huang JY, Tulandi T, Holzer H, et al. Cryopreservation of ovarian tissue and in vitro matured oocytes in a female with mosaic Turner syndrome: Case Report. Hum Reprod 2008; 23:336-339.
33. Oktay K, Demirtas E, Son WY, et al. In vitro maturation of germinal vesicle oocytes recovered after premature luteinizing hormone surge: description of a novel approach to fertility preservation. Fertil Steril 2008; 89:228.e19- 228.22.
34. Oktay K, Buyuk E, Veeck L, et al. Embryo development after heterotopic transplantation of cryopreserved ovarian tissue. Lancet 2004; 363:837- 840.
35. Donnez J, Dolmans MM, Demylle D, et al. Live birth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 2004; 364:1405- 1410.
36. Meirow D, Levron J, Eldar-Geva T, et al. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med 2005; 353:318-321.
37. Oktay K. Spontaneous conceptions and live birth after heterotopic ovarian transplantation: is there agermlinestem cell connection? Hum Reprod 2006; 21:1345-1348.
38. Demeestere I, Simon P, Buxant F, et al. Ovarian function and spontaneous pregnancy after combined heterotopic and orthotopic cryopreserved ovarian tissue transplantation in a patient previously treated with bone marrow transplantation: case report. Hum Reprod 2006; 21:2010-2014.
39. Bedaiwy MA, Hussein MR, Biscotti C, Falcone T. Cryopreservation of intact human ovary with its vascular pedicle. Hum Reprod 2006; 21:3258-3269.
40. Martinez-Madrid B, Camboni A, Dolmans MM, et al. Apoptosis and ultra-structural assessment after cryopreservation of whole human ovaries with their vascular pedicle. Fertil Steril 2007; 87:1153-1165.
41. Arav A, Revel A, Nathan Y, Bor A, et al. Oocyte recovery, embryo development and ovarian function after cryopreservation and transplantation of whole sheep ovary. Hum Reprod 2005; 20:3554-3559.
42. Oktay K, Sonmezer M,Oktem O, et al. Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury. Oncologist 2007; 12:1055-1066.
43. Johnson J, Bagley J, Skaznik-Wikiel M, et al. Oocyte generation in adult mammalian ovaries by putative germ cells in bone marrow and peripheral blood. Cell 2005; 122:303-315.
44. Oktay K, Oktem O. Regeneration of oocytes after chemotherapy: connecting the evidence from mouse to human. J Clin Oncol 2007; 25:3185-3187.